Johnson & Johnson Pauses COVID Vaccine Trials After ‘Unexplained Illness’
By Jeremy Loffredo
OCTOBER 14, 2020
Johnson & Johnson temporarily paused Phase 3 clinical trials of its COVID-19 vaccine on Monday after one participant experienced what the company termed “an unexplained illness.”
The multinational maker of packaged consumer goods, medical devices and pharmaceuticals declined to provide details about the reaction or illness, leaving the public and thousands of other trial participants in the dark.
